HBAR Price Prediction Eyes $0.11 as Remittix Sets a $0.46 Final Stage and Experts Forecast $3.50

HBAR faces renewed focus as price nears $0.11 after a 20% weekly gain, with Hedera’s enterprise governance and stable costs cited as core drivers for sustained demand. The piece also highlights Remittix (RTX) pre-sale dynamics, noting a final stage at $0.46 and speculative price targets like $3.50, while emphasizing execution risk and the need for liquidity and real product use. Key takeaways: monitor resistance at $0.11, enterprise adoption, and how Remittix milestones could influence Hedera-linked demand.